Your browser is no longer supported. Please, upgrade your browser.
Settings
HSKA Heska Corporation daily Stock Chart
HSKA [NASD]
Heska Corporation
Index- P/E60.01 EPS (ttm)1.79 Insider Own4.40% Shs Outstand7.26M Perf Week2.63%
Market Cap781.61M Forward P/E53.32 EPS next Y2.02 Insider Trans-10.70% Shs Float6.71M Perf Month1.08%
Income13.40M PEG2.40 EPS next Q0.16 Inst Own90.20% Short Float8.61% Perf Quarter35.49%
Sales131.70M P/S5.93 EPS this Y45.30% Inst Trans0.03% Short Ratio8.66 Perf Half Y33.89%
Book/sh14.80 P/B7.27 EPS next Y21.85% ROA5.60% Target Price116.50 Perf Year5.01%
Cash/sh1.67 P/C64.60 EPS next 5Y25.00% ROE7.40% 52W Range56.59 - 115.00 Perf YTD34.22%
Dividend- P/FCF79.76 EPS past 5Y56.80% ROI14.30% 52W High-6.38% Beta0.80
Dividend %- Quick Ratio1.40 Sales past 5Y12.20% Gross Margin44.30% 52W Low90.25% ATR3.42
Employees345 Current Ratio2.70 Sales Q/Q10.80% Oper. Margin13.10% RSI (14)55.27 Volatility2.37% 3.91%
OptionableNo Debt/Eq0.06 EPS Q/Q-53.90% Profit Margin5.70% Rel Volume0.25 Prev Close107.68
ShortableYes LT Debt/Eq0.00 EarningsAug 03 BMO Payout0.00% Avg Volume66.71K Price107.66
Recom2.00 SMA202.06% SMA504.53% SMA20024.75% Volume16,580 Change-0.02%
May-18-18Reiterated Canaccord Genuity Buy $100 → $115
May-18-18Reiterated B. Riley FBR, Inc. Neutral $77 → $93
May-07-18Reiterated The Benchmark Company Buy $90 → $100
Mar-01-18Reiterated B. Riley FBR, Inc. Neutral $93 → $77
Feb-05-18Upgrade Sidoti Neutral → Buy $94
Nov-03-17Reiterated B. Riley FBR, Inc. Neutral $96.50 → $93
Aug-03-17Reiterated The Benchmark Company Buy $106 → $120
Mar-01-17Reiterated The Benchmark Company Buy $100 → $106
Jan-26-17Downgrade CL King Buy → Neutral
Nov-29-16Initiated The Benchmark Company Buy $78
Aug-04-16Downgrade Gabelli & Co Buy → Hold
Jul-01-16Initiated Sidoti Buy
Apr-01-16Initiated CL King Buy
Dec-12-14Initiated Gabelli & Co Buy $20
Aug-08-13Reiterated Feltl & Co. Strong Buy $12.50 → $9.50
Sep-11-12Initiated Feltl & Co. Strong Buy $13.50
Aug-13-12Downgrade C.K. Cooper Buy → Hold
Jun-08-12Initiated C.K. Cooper Buy $20
Jul-16-18 04:35PM  As America's hiring spree continues, these Denver companies are leading the charge American City Business Journals
Jul-09-18 07:54AM  New Strong Sell Stocks for July 9th Zacks
Jun-22-18 03:31PM  Does Heska Corporations (NASDAQ:HSKA) PE Ratio Signal A Selling Opportunity? Simply Wall St.
Jun-14-18 04:05PM  Pathway Vet Alliance, Heska Corporation announce multi-year strategic partnership aimed at elevating veterinary care nationwide PR Newswire
May-24-18 07:50AM  Recent Analysis Shows Alexander's, American National Insurance, VAREX IMAGING, Banner, Instructure, and Heska Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
May-17-18 07:40AM  Wired News Heska Collaborates with MBio Diagnostics for Developing New Products for the Veterinary Market ACCESSWIRE
May-08-18 05:50PM  Edited Transcript of HSKA earnings conference call or presentation 4-May-18 3:00pm GMT Thomson Reuters StreetEvents
May-04-18 08:09AM  Heska: 1Q Earnings Snapshot Associated Press +5.07%
08:00AM  Heska Reports First Quarter Results PR Newswire
May-03-18 08:42AM  Why Heska (HSKA) Might Surprise This Earnings Season Zacks
08:00AM  Heska to Present at Upcoming Conferences in May & June 2018 PR Newswire
May-02-18 03:34PM  Heska Corporation Announces Board Action PR Newswire
08:00AM  Heska to Host Analyst and Investor Day on May 15 PR Newswire
Apr-30-18 08:00AM  Heska Names EVP, International Diagnostics, to Accelerate International Expansion PR Newswire
Apr-25-18 08:00AM  Heska Confirms Details for Annual Meeting of Stockholders on May 3, 2018 PR Newswire
Apr-10-18 08:00AM  Heska Schedules First Quarter 2018 Financial Results Conference Call for May 4, 2018 PR Newswire
Apr-06-18 08:00AM  Heska Schedules Annual Meeting of Stockholders for May 3, 2018 PR Newswire
Apr-02-18 07:30AM  Research Report Identifies Werner Enterprises, Midland States, First, German American, Heska, and Sigma Designs with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Mar-02-18 06:05AM  Edited Transcript of HSKA earnings conference call or presentation 28-Feb-18 4:00pm GMT Thomson Reuters StreetEvents
Feb-28-18 09:03AM  Heska reports 4Q loss Associated Press +13.89%
08:50AM  Heska Corporation to Host Earnings Call ACCESSWIRE
07:00AM  Heska Reports Fourth Quarter and Full Year 2017 Results PR Newswire
Feb-09-18 08:00AM  Heska Schedules Fourth Quarter and Year End 2017 Financial Results Conference Call for February 28, 2018 PR Newswire
Jan-30-18 07:30AM  Consolidated Research: 2018 Summary Expectations for Immune Design, Primoris Services, Scotts Miracle-Gro, Heska, Calyxt, and Urstadt Biddle Properties Fundamental Analysis, Key Performance Indications GlobeNewswire
Dec-01-17 04:05PM  Heska promotes Catherine Grassman to Vice President and Chief Accounting Officer and announces executive departure PR Newswire
Nov-27-17 02:09PM  ETFs with exposure to Heska Corp. : November 27, 2017 Capital Cube
Nov-21-17 12:33PM  Mariko Gordon Starts 5 New Positions in 3rd Quarter GuruFocus.com
Nov-06-17 06:16PM  Edited Transcript of HSKA earnings conference call or presentation 2-Nov-17 3:00pm GMT Thomson Reuters StreetEvents
01:07PM  Heska Corp. Value Analysis (NASDAQ:HSKA) : November 6, 2017 Capital Cube
Nov-03-17 08:34AM  Heska Corp. breached its 50 day moving average in a Bearish Manner : HSKA-US : November 3, 2017 Capital Cube +6.09%
Nov-02-17 08:25AM  Heska beats 3Q profit forecasts Associated Press -15.74%
08:00AM  Heska Reports Third Quarter Results PR Newswire
Nov-01-17 08:00AM  Heska Announces 7-Year Agreement with PetVetCare Centers PR Newswire
Oct-31-17 08:00AM  Heska extends product line with new Element COAG Veterinary Analyzer PR Newswire
Oct-30-17 11:57AM  ETFs with exposure to Heska Corp. : October 30, 2017 Capital Cube
Oct-12-17 08:00AM  Heska Schedules Third Quarter 2017 Financial Results Conference Call for November 2, 2017 PR Newswire
Oct-09-17 11:38AM  ETFs with exposure to Heska Corp. : October 9, 2017 Capital Cube
08:41AM  Heska Corp. breached its 50 day moving average in a Bearish Manner : HSKA-US : October 9, 2017 Capital Cube
Oct-06-17 09:04AM  Heska Corp. :HSKA-US: Earnings Analysis: Q2, 2017 By the Numbers : October 6, 2017 Capital Cube
Sep-18-17 10:01AM  TESARO Ovarian Cancer Drug Zejula Gets Positive CHMP Opinion Zacks
Sep-15-17 11:22AM  The Zacks Analyst Blog Highlights: KEMET, Heska, Spirit AeroSystems, American Woodmark and Kraton Zacks
Sep-14-17 05:39PM  4 Biotech Stocks That Show Promise on Sustainable Growth Zacks
09:33AM  Obama-Trump Bull Run is the Second Best Ever: Top 5 Gainers Zacks
Aug-28-17 11:01AM  Zacks.com featured highlights Sanderson Farm, Heska Corp, Vanda Pharmaceuticals Lantheus and NVR Zacks
Aug-25-17 10:43AM  5 Efficient Stocks to Buy for a Healthy Portfolio Zacks
Aug-24-17 08:26AM  Heska Corp. breached its 50 day moving average in a Bullish Manner : HSKA-US : August 24, 2017 Capital Cube
Aug-23-17 04:11PM  Edited Transcript of HSKA earnings conference call or presentation 31-Jul-17 3:00pm GMT Thomson Reuters StreetEvents
08:00AM  Heska to Present at CL King's 15th Annual Best Ideas Conference 2017 on September 14, 2017 PR Newswire
Aug-16-17 09:16PM  Heska Corp. Value Analysis (NASDAQ:HSKA) : August 17, 2017 Capital Cube
Aug-04-17 09:50AM  Heska Corp. breached its 50 day moving average in a Bearish Manner : HSKA-US : August 4, 2017 Capital Cube
Jul-31-17 11:02PM  Heska posts 2Q profit Associated Press
08:00AM  Heska Reports Second Quarter Results PR Newswire
06:45AM  Investor Network: HESKA CORP to Host Earnings Call ACCESSWIRE
Jul-27-17 07:34PM  Heska Adds Growth Capital with $30 Million Credit Agreement with JPMorgan Chase PR Newswire
Jul-20-17 04:05PM  Heska to Present at Canaccord Genuity 37th Annual Growth Conference on August 10 PR Newswire
Jul-11-17 02:38PM  ETFs with exposure to Heska Corp. : July 11, 2017 Capital Cube
08:00AM  Heska Schedules Second Quarter 2017 Financial Results Conference Call for July 31, 2017 PR Newswire
Jun-30-17 03:02PM  ETFs with exposure to Heska Corp. : June 30, 2017 Capital Cube
Jun-22-17 08:09AM  Heska Corp. breached its 50 day moving average in a Bullish Manner : HSKA-US : June 22, 2017 Capital Cube
Jun-19-17 03:29PM  ETFs with exposure to Heska Corp. : June 19, 2017 Capital Cube
Jun-16-17 11:50AM  Heska Corp. :HSKA-US: Earnings Analysis: Q1, 2017 By the Numbers : June 16, 2017 Capital Cube
Jun-13-17 09:00AM  Scott Humphrey Joins Heska's Board of Directors PR Newswire
Jun-08-17 02:05PM  Edited Transcript of HSKA earnings conference call or presentation 2-May-17 3:00pm GMT Thomson Reuters StreetEvents
Jun-02-17 08:46AM  Why Heska (HSKA) Could Be Positioned for a Surge Zacks
May-26-17 08:27AM  Heska Corp. breached its 50 day moving average in a Bearish Manner : HSKA-US : May 26, 2017 Capital Cube
May-04-17 04:51PM  Heska Corp. Value Analysis (NASDAQ:HSKA) : May 4, 2017 Capital Cube
08:00AM  Edited Transcript of HSKA earnings conference call or presentation 2-May-17 3:00pm GMT Thomson Reuters StreetEvents
May-03-17 08:46AM  Heska Corp. breached its 50 day moving average in a Bearish Manner : HSKA-US : May 3, 2017 Capital Cube -5.00%
May-02-17 12:33PM  Here's Why Heska Corporation Is Dropping Today Motley Fool -14.21%
08:15AM  Heska posts 1Q profit Associated Press
08:05AM  Investor Network: Heska Corporation to Host Earnings Call Accesswire
08:00AM  Heska Reports First Quarter Results PR Newswire
May-01-17 09:59AM  Hill-Rom (HRC) Beats Earnings & Revenue Estimates in Q2 Zacks
Apr-28-17 10:43AM  Sarepta (SRPT) Q1 Loss Narrows, Exondys 51 Sales Pick Up Zacks
09:57AM  Seattle Genetics (SGEN) Q1 Loss Widens, Sales Top Estimates Zacks
09:31AM  Align Technology (ALGN) Beats on Q1 Earnings and Revenues Zacks
Apr-27-17 09:03AM  Chemed's (CHE) Earnings and Revenues Beat Estimates in Q1 Zacks
08:00AM  Heska To Present at Four Upcoming Conferences PR Newswire
Apr-26-17 11:10AM  Medical Device Maker Bolts Higher On Earnings In Massive Volume Investor's Business Daily
Apr-25-17 05:19PM  Reminder: Heska Annual Meeting of Stockholders on May 1, 2017 PR Newswire
Apr-20-17 06:07PM  CytRx Gets Clarity from FDA for Aldoxorubicin NDA, Shares Up Zacks
09:30AM  Zacks.com featured highlights: Heska, Zeltiq Aesthetics, YY, MaxLinear and Teradyne Zacks
Apr-19-17 10:38AM  Ultragenyx's Hypophosphatemia Drug Succeeds in Phase III Zacks
07:42AM  Create an Efficient Portfolio with 5 Top Stocks Zacks
Apr-18-17 10:08AM  Bristol-Myers and Nordic Ink Biomarker Collaboration Deal Zacks
09:29AM  Rigel Pharmaceuticals Files NDA for Thrombocytopenia Drug Zacks
Apr-17-17 09:47AM  Eli Lilly's Rheumatoid Arthritis Drug Gets CRL in the U.S. Zacks
Apr-13-17 08:58AM  Illumina (ILMN) Launches VeriSeq NIPT Solution in Europe Zacks
08:00AM  Heska Schedules First Quarter 2017 Financial Results Conference Call for May 2, 2017 PR Newswire
Apr-12-17 08:00AM  Heska Schedules Annual Meeting of Stockholders for May 1, 2017 PR Newswire
Apr-10-17 05:27PM  Gilead (GILD) HCV Drugs Gets FDA Nod for Label Expansion Zacks
05:18PM  Roche's Lung Cancer Drug Alecensa Meets Primary Endpoint Zacks
Apr-06-17 09:57AM  Bristol-Myers' (BMY) sBLA For Opdivo Accepted by the FDA Zacks
Apr-05-17 08:35PM  Today's Strong Buy Stocks at New Highs Zacks
03:36PM  Celgene (CELG) Gets Paragraph IV Notice Letter for Pomalyst Zacks
12:48PM  Roche Announces Positive Data on Lung Cancer Drug Alecensa Zacks
09:10AM  Amedisys (AMED) Poised on Strong Home Health, Risks Remain Zacks
Apr-04-17 12:01PM  Bristol-Myers Announces Data on Immuno-oncology Drug Opdivo Zacks
11:12AM  QIAGEN Releases Favorable GeneReader Results, Expands in NGS Zacks
09:30AM  Zacks.com featured highlights: Heska, Quidel, Trinseo S.A., Advanced Energy Industries and Pioneer Natural Resources Zacks
Heska Corporation manufactures, sells, and markets veterinary diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Europe, and internationally. The company's Core Companion Animal Health segment offers Element DC and DRI-CHEM 7000 veterinary chemistry analyzers for blood chemistry and electrolyte analysis; HT5 and HEMATRUE veterinary hematology analyzers to measure blood cell and platelet count, and hemoglobin levels; Element POC blood gas and electrolyte analyzers; COAG veterinary analyzers; Element i immunodiagnostic analyzers; and IV infusion pumps. This segment also provides veterinary imaging instruments and services, such as digital radiography solutions and ultrasound systems, as well as sells mobile digital radiography products; Cloudbank, a Web-based image storage solution; ViewCloud, a picture archival and communications system for Cloudbank; point-of-care heartworm diagnostic test products for dogs and cats; TRI-HEART Plus chewable tablets for the treatment of canine heartworm infection, and treatment and control of ascarid and hookworm infections; and allergy products and services, including ALLERCEPT definitive allergen panels, and therapy shots or drops. Its Other Vaccines, Pharmaceuticals and Products segment offers bovine vaccines primarily under the Titanium and MasterGuard brands; biological and pharmaceutical products for other animal health companies; and turnkey services comprising research, licensing, production, labeling, and packaging. The company sells its products to veterinarians through a field organization and third-party distributors; and trade shows, print advertising, and other distribution relationships. Heska Corporation has product development partnership and licensing agreement with MBio Diagnostics, Inc. The company was formerly known as Paravax, Inc. and changed its name to Heska Corporation. Heska Corporation was founded in 1988 and is headquartered in Loveland, Colorado.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
NAPOLITANO JASON ACOO, Chief Strategist and Sec.Jul 09Sale110.001,200132,00029,374Jul 11 04:11 PM
Wisnewski NancyEVP, Diag. Ops & Prod. Dev.Jun 08Sale106.5075079,87534,873Jun 11 04:30 PM
GORDON G IRWINDirectorJun 08Sale106.183,400361,02516,606Jun 11 04:26 PM
GORDON G IRWINDirectorJun 07Sale103.863,400353,12920,006Jun 11 04:21 PM
GORDON G IRWINDirectorJun 06Sale105.773,400359,61323,406Jun 08 05:10 PM
GORDON G IRWINDirectorJun 05Sale105.663,400359,24026,806Jun 07 04:03 PM
GORDON G IRWINDirectorJun 04Sale105.743,400359,52830,206Jun 06 03:53 PM
Wisnewski NancyEVP, Diag. Ops & Prod. Dev.Jun 01Sale108.202,250243,45835,623Jun 01 04:38 PM
NAPOLITANO JASON ACOO, Chief Strategist and Sec.Jun 01Sale108.502,500271,25030,574Jun 01 04:22 PM
NAPOLITANO JASON ACOO, Chief Strategist and Sec.May 31Sale107.5050253,965100May 31 04:36 PM
NAPOLITANO JASON ACOO, Chief Strategist and Sec.May 31Sale106.803,131334,39132,074May 31 04:36 PM
Wisnewski NancyEVP, Diag. Ops & Prod. Dev.May 30Sale105.731,200126,88137,873May 31 04:42 PM
NAPOLITANO JASON ACOO, Chief Strategist and Sec.May 30Sale105.302,869302,10635,205May 31 04:36 PM
Trowbridge Bonnie J.DirectorMay 29Option Exercise28.415,000142,0506,249May 31 04:39 PM
Wisnewski NancyEVP, Diag. Ops & Prod. Dev.May 29Sale102.661,300133,45739,073May 31 04:42 PM
Trowbridge Bonnie J.DirectorMay 29Sale101.015,000505,0381,249May 31 04:39 PM
Eyl Steven M.EVP, Global Sales & MarketingMay 18Sale103.0058259,9469,900Jul 11 04:08 PM
NAPOLITANO JASON ACOO, Chief Strategist and Sec.Dec 28Option Exercise18.3011,000201,30043,119Dec 29 04:43 PM
Wisnewski NancyEVP, Diag. Ops & Prod. Dev.Dec 13Option Exercise18.307,000128,10045,128Dec 15 01:57 PM
McGinley Michael JPresi, Biologic. & Pharm.Nov 30Sale86.026,500559,12492,446Dec 04 02:40 PM
McGinley Michael JPresi, Biologic. & Pharm.Nov 29Sale87.027,025611,28298,946Nov 29 06:16 PM
McGinley Michael JPresi, Biologic. & Pharm.Nov 28Sale88.1980070,549105,971Nov 29 06:16 PM
McGinley Michael JPresi, Biologic. & Pharm.Nov 27Sale88.54189106,771Nov 29 06:16 PM
Wisnewski NancyEVP, Diag. Ops & Prod. Dev.Aug 31Sale102.2182584,32738,114Aug 31 05:28 PM
McMahon JohnVP, Chief Financial OfficerAug 30Option Exercise63.322,608165,1442,676Aug 31 05:26 PM
McMahon JohnVP, Chief Financial OfficerAug 30Sale101.172,608263,85768Aug 31 05:26 PM